This article was originally published in The Rose Sheet
Executive SummaryMarket View Current Conditions Report, launching now, provides NPD clients "deeper insight" into the prestige beauty market with national and regional information as well as new measures such as sales rates and distribution, according to an Aug. 5 release from the beauty market research company. "With more granular sales data, manufacturers and their retail partners can better understand their consumers and develop, monitor and improve marketing and sales efficiencies," says Diane Nicholson, president, Beauty, The NPD Group. Based on data provided by participating retailers on a weekly basis, NPD's report gives clients a monthly view of new information so they can "refine their sell-in strategies, discover regional opportunities, and understand how distribution and sales rates impact market share," firm notes
You may also be interested in...
In an exclusive interview with Medtech Insight, Mark Leahey, president of the Medical Device Manufacturers Association (MDMA), said the previous four Medical Device User Fee negotiations with the US FDA have set a strong foundation for the industry and the next round of negotiations should focus on tweaking past deals that are already in place. See what MDMA's president, Mark Leahey, said about it here.
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.